NOVT | NovantaNASDAQIndustrialsCommon stock golden cross and death cross projections, cross tests and history

$147.49
+$1.25 (+0.85%)

Novanta (NOVT) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.

The 50 SMA has sat above the 200 on the daily since Nov 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits above the 50 and the 200; on the weekly it is between the two.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
above both $147.49 vs 50 $142.50 / 200 $142.43
Projection
No cross projected
Test
Cross test window open, no test bar yet
Last cross
Death cross 2 Nov 2026 ยท projected 11 bars out

Weekly as of 30 Oct 16:00 ET

Price
between the two $145.76 vs 50 $138.24 / 200 $147.72
Projection
Golden cross estimated 15+ weeks out
Test
No active test
Last cross
Death cross week of 23 Jun 2025 ยท projected 21 bars out

Cross history

29
crosses on record since 2018
13 golden16 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
2 Nov 2026Death moderatedaily11 bars outActive Cross Test
15 Sep 2026Death4-hour30 bars outNot tested
11 May 2026Golden4-hour10 bars outNot tested
31 Mar 2026Death4-hour30 bars outNot tested
26 Jan 2026Golden moderatedaily19 bars outNot tested

About NOVT

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$49.7M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorIndustrials
Cap bandmid

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.